Role of MMP-1 1G/2G promoter gene polymorphism on the development of prostate cancer in the Turkish population

Urologia Internationalis

Volumn 79, Issue 4, 2007, Pages 312-315

  Albayrak, Selami ^a   Cangüven, Önder ^a,c   Göktaş, Cemal ^a   Aydemir, Hüseyin ^a   Köksal, Vedat ^b  

^a Kartal Training Hospital   (Turkey)

^b BURC Molecular Diagnostic Laboratory Turkey   (Turkey)

^c NONE   (Turkey)

Author keywords

Matrix metalloproteinase 1 gene; Prostate cancer; Single nucleotide polymorphism

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; DNA POLYMORPHISM; GENE FREQUENCY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; SMOKING;

AGED; AGED, 80 AND OVER; ALLELES; BIOPSY, NEEDLE; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MIDDLE AGED; NEOPLASM STAGING; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; PROBABILITY; PROGNOSIS; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; REFERENCE VALUES; TURKEY;

EID: 36248954428     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000109715     Document Type: Article

References (19)

1. Brinckerhoff CE, Rutter JL, Benbow U: Interstitial collagenases as markers of tumor progression. Clin Cancer Res 2000;6:4823-4830.
2. Rutter JL, Mitchell TI, Buttice G, Meyers J, Gusella JF, Ozelius LJ, Brinckerhoff CE: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998;58:5321-5325.
3. Hirata H, Naito K, Yoshihiro S, Matsuyama H, Suehiro Y, Hinoda Y: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter is associated with conventional renal cell carcinoma. Int J Cancer 2003;106:372-374.
4. Hirata H, Naoko O, Katsusuke N, Ryo I, Satoru Y: Association of a haplotype of matrix metalloproteinase (MMP)-1 and MMP3 polymorphisms with renal cell carcinoma. Carcinogenesis 2004;12:2379-2384.
5. Zhu Y, Spitz MR, Lei L, Mills GB, Wu X: A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 2001;61:7825-7829.
6. Hinoda Y, Okayama N, Takano N, Fujimura K, Suehiro Y, Hamanaka Y, Hazama S, Kitamura Y, Kamatani N, Oka M: Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. Int J Cancer 2002;102:526-529.
7. Ye S, Dhillon S, Turner SJ, Bateman AC, Theaker JM, Pickering RM, Day I, Howell WM: Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase-1 gene polymorphism. Cancer Res 2001;61:1296-1298.
8. Kanamori Y, Matsushima M, Minaguchi T, Kobayashi K, Sagae S, Kudo R, Terakawa N, Nakamura Y: Correlation between expression of the matrix metalloproteinase-1 gene in ovarian cancers and an insertion/deletion polymorphism in its promoter region. Cancer Res 1999;59:4225-4227.
9. Nishioka Y, Sagae S, Nishikawa A, Ishioka S, Kudo R: A relationship between matrix metalloproteinase-1 promoter polymorphism and cervical cancer progression. Cancer Lett 2003;200:49-55.
10. Ghilardi G, Biondi ML, Mangoni J, Leviti S, DeMonti M, Guagnellini E, Scorza R: Matrix metalloproteinase-1 promoter polymorphism 1G/2G is correlated with colorectal cancer invasiveness. Clin Cancer Res 2001;7:2344-2346.
11. D'Armiento J, Di Colandrea T, Dalal SS, Okada Y, Huang MT, Conney AH, Chada K: Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol Cell Biol 1995;15:5732-5739.
12. Murray GI, Duncan ME, Arbuckle E, Melvin WT, Fothergill JE: Matrix metalloproteinases and their inhibitors in gastric cancer. Gut 1998;43:791-797.
13. Hewitt RE, Leach IH, Powe DG, Clark IM, Cawston TE, Turner DR: Distribution of collagenase and tissue inhibitor of metalloproteinases in colorectal tumours. Int J Cancer 1991;49:666-672.
14. Templeton NS, Brown PD, Levy AT, Margulies IM, Liotta LA, Stetler-Stevenson WG: Cloning and characterization of human tumor cell interstitial collagenase. Cancer Res 1990;50:5431-5437.
15. Murray GI, Duncan ME, O'Neil P, Melvin WT, Fothergill JE: Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996;2:461-462.
16. Murray GI, Duncan ME, O'Neil P, McKay JA, Melvin WT, Fothergill JE: Matrix metalloproteinase-1 is associated with poor prognosis in oesophageal cancer. J Pathol 1998;185:256-261.
17. Lukashev ME, Werb Z: ECM signalling: orchestrating cell behaviour and misbehaviour. Trends Cell Biol 1998;8:437-441.
18. Singer CF, Marbaix E, Kokorine I, Lemoine P, Donnez J, Eeckhout Y, Courtoy PJ: Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin-1α and its dual block by ovarian steroids. Proc Natl Acad Sci USA 1997;94:10341-10345.
19. Wyatt CA, Coon CI, Gibson JJ, Brinckerhoff CE: Potential for the 2G single nucleotide polymorphism in the promoter of matrix metalloproteinase to enhance gene expression in normal stromal cells. Cancer Res 2002;62:7200-7202.